SREBF2 promotes osteoporosis by activating Hippo/YAP to drive adipogenesis while inhibiting BMP/Smad to suppress osteogenesis in BMSCs. Targeting SREBF2 is a promising therapeutic strategy.
Building similarity graph...
Analyzing shared references across papers
Loading...
Dawei Xiao
Yifei Li
Tongji University
Bo Liu
Fuyang City People's Hospital
Connective Tissue Research
Anhui Medical University
Second Hospital of Anhui Medical University
Fuyang Normal University
Building similarity graph...
Analyzing shared references across papers
Loading...
Xiao et al. (Tue,) studied this question.
synapsesocial.com/papers/69d893c96c1944d70ce04c81 — DOI: https://doi.org/10.1080/03008207.2026.2650791
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: